ABTL-0815

N/A

Report date: 2023/01/08 19:05:49
NME

Base Information

Drug NameABTL-0815
Drug Alias NameABTL-0814ABTL-0815ABTL-1014ABTL-1216LP-20104
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHematologic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAbility Pharm
China Registration ClassN/A

Develop Information

Active CompaniesAbility Pharm
Inactive CompaniesN/A
Active IndicationsHematologic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A